Should You Buy Pro-Dex, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Pro-Dex, Inc. (PDEX) is rated as a strong fundamental performer with a QOC score of 8.2/10. Trading at $66.91, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 4 of 10 CirclFi valuation models project upside for Pro-Dex, Inc. (PDEX) at $66.91 — the model consensus leans bearish, with a Quality Score of 8.2/10 and Value-Trap risk of 43/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Pro-Dex, Inc. (PDEX) in 2026?
What Is the Bull Case vs the Bear Case for Pro-Dex, Inc. (PDEX)?
| Bull case — $112.34 target (+67.9%) | Bear case — $6.15 target (-90.8%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Pro-Dex, Inc.'s quality score of 8.2/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Value Trap algorithm, the stock shows moderate caution signals, meaning investors should verify that apparent undervaluation isn't masking declining business quality. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $112.34 (+67.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, the Bayesian DCF model sees the stock as overvalued with a fair value of $6.15 (-90.8%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +158.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
How Does PDEX Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: NVST · UTMD · BDX · RGEN · ALGN · EMBC · BLFS · STXS · ZJYL · ISRG · RMD
Which Other Stocks Score Like PDEX on Quality?
Closest companies to PDEX’s Quality of Company score of 8.2/10, across all industries.
- PLD — Prologis, Inc. (QOC 8.2) · analysis
- CHE — Chemed Corporation (QOC 8.2) · analysis
- PJT — PJT Partners Inc. (QOC 8.2) · analysis
- USAQ — QHSLab, Inc. (QOC 8.2) · analysis
- SHOO — Steven Madden, Ltd. (QOC 8.2) · analysis
- VAL — Valaris Limited (QOC 8.2) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does PDEX Appear In?
So Is Pro-Dex, Inc. (PDEX) Worth Buying in 2026?
Our models don't have a clear verdict on Pro-Dex, Inc.. At $66.91 vs. $57.76 median fair value, the median upside of -13.7% masks significant model disagreement (+158.7% spread). With quality at 8.2/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Pro-Dex, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About PDEX Stock?
Should I buy PDEX stock right now?
Based on CirclFi's multi-model analysis, 4 of 10 models see upside for PDEX at $66.91. The models are divided, which means the investment case depends heavily on your assumptions about Pro-Dex, Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Pro-Dex, Inc.?
Key risks include: an elevated Value Trap score of 43/100, suggesting apparent undervaluation may mask deteriorating fundamentals; wide model disagreement (1728% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does PDEX compare to its competitors?
Among Medical Instruments & Supplies peers, PDEX holds a Quality Score of 8.2/10. Comparable companies include NVST (QOC 8.3), UTMD (QOC 8.2), BDX (QOC 8.3). The relative ranking helps investors identify whether PDEX offers better fundamental quality than alternatives in the same sector.
Is PDEX a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. PDEX's Quality Score of 8.2/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy PDEX at?
CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $6.15 to $112.34. At $66.91, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for PDEX.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad